In ER+ breast tumors MRPS30 expression correlated strongly with expression of genes in the estrogen signaling pathway. MRPS30 expression is increased in response to estrogen in MPE600 cells which are homozygous for the risk allele. The gene discussed is MRPS30; the disease is breast neoplasm.